Syngenta Group has officially withdrawn its long-pending application for a $9 billion initial public offering (IPO) in Shanghai, marking another setback for China’s equity markets. This decision follows in the wake of Alibaba Group Holding Ltd. canceling the listing of its logistics arm earlier this week.
The Chinese-owned agricultural giant stated on Friday that it intends to resume the listing process at a later stage, either in China or on a different global exchange, when market conditions are favorable. Additionally, it plans to explore alternative funding avenues.
This development underscores the challenges facing Chinese equities amidst a sluggish economy, exacerbated by persistent real estate woes, deflationary pressures, and geopolitical uncertainties. Despite record highs in US and European stocks, China’s benchmark CSI 300 Index hit a five-year low in February, plummeting 39% from its peak in 2021.
The withdrawal of Syngenta’s IPO application comes after years of setbacks and delays. The company initially filed for an IPO in Shanghai in 2021 but encountered various hurdles along the way. The most recent postponement occurred in November due to volatile market conditions, with plans to reconsider the offering by the end of 2024.
Syngenta’s decision to withdraw the listing is attributed to a careful assessment of industry conditions and its own strategic trajectory. Acquired by China National Chemical Corp. (ChemChina) in 2017 for a record $43 billion, Syngenta’s role in bolstering China’s food security through its products, including genetically modified seeds, remains significant.
Despite the challenges in the equity markets, developments elsewhere indicate a resurgence in global IPO activity, with companies like Reddit Inc. and Galderma Group AG making notable debuts. As Syngenta regroups, the future trajectory of its listing remains uncertain amidst broader economic and geopolitical dynamics.
